Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg ... - MarketWatch (press release)

Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg ... MarketWatch (press release) About DUEXIS DUEXIS, a proprietary single-tablet combination of the NSAID ibuprofen and the histamine H2-receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the ... Horizon Pharma Announces Launch of DUEXIS 800 mg/26.6 mg in the United StatesBenzinga all 9 news articles »

It's all in the mind - Manila Bulletin

It's all in the mind Manila Bulletin It is more effective in subjective disorders (eg, depression, headache, back and other forms of pain, migraine, rheumatoid arthritis and angina) than in objective ones. Although, there are some objective signs such as blood pressure, heart rate, ...

Galapagos GLPG0634 Phase II study meets primary endpoint - Pharmaceutical Business Review

Galapagos GLPG0634 Phase II study meets primary endpoint Pharmaceutical Business Review Galapagos' JAK1 inhibitor, GLPG0634 met its primary endpoint of improvement in the signs and symptoms of rheumatoid arthritis (RA), as evident from phase II study data. GLPG0634 is a selective inhibitor of JAK1 (Janus kinase 1) used for treating ... Galapagos' GLPG0634 shows excellent efficacy and safety in rheumatoid ...Reuters (press release) all 18 news articles »

15-year-old arthritis victim to lead Jingle Bell Run - Tulsa World

15-year-old arthritis victim to lead Jingle Bell Run Tulsa World She has to wear two knee braces to play soccer because of her arthritis. She's been dealing with juvenile rheumatoid arthritis for about four years. She takes more than 20 medications daily and some days she is in so much pain she has to miss school. ... and more »